Search research articles
Contact Us
Filters
Showing results (91-100 of 171) with videos related to
Page
of 18
Sort By:
Nucleic Acids Research
|
November 17, 2012
DiffSplice: the genome-wide detection of differential splicing events with RNA-seq
Yin Hu, Yan Huang, Ying Du, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2012
Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elements
D Neil Hayes, Amy S Lucas, Tawee Tanvetyanon, et al.
Oncogene
|
May 16, 2022
TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice
Samera H Hamad, Stephanie A Montgomery, Jeremy M Simon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2007
Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands
Mark Agulnik, Ezra W E Cohen, Roger B Cohen, et al.
Pigment Cell & Melanoma Research
|
March 18, 2014
Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma
William R Jeck, Joel Parker, Craig C Carson, et al.
Oncogene
|
August 24, 2022
Correction: TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice
Samera H Hamad, Stephanie A Montgomery, Jeremy M Simon, et al.
The Journal of Pathology
|
July 4, 2020
A conditional mouse expressing an activating mutation in NRF2 displays hyperplasia of the upper gastrointestinal tract and decreased white adipose tissue
Brittany M Bowman, Stephanie A Montgomery, Travis P Schrank, et al.
Cancer
|
May 10, 2012
Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN)
K Kian Ang, Amy Chen, Walter J Curran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 6, 2013
Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial
Renato G Martins, Upendra Parvathaneni, Julie E Bauman, et al.
Plos One
|
April 6, 2012
Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma
Chad J Creighton, Anadulce Hernandez-Herrera, Anders Jacobsen, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 171) with videos related to
Sort By:
Page
of 18
Nucleic Acids Research
|
November 17, 2012
DiffSplice: the genome-wide detection of differential splicing events with RNA-seq
Yin Hu, Yan Huang, Ying Du, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2012
Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elements
D Neil Hayes, Amy S Lucas, Tawee Tanvetyanon, et al.
Oncogene
|
May 16, 2022
TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice
Samera H Hamad, Stephanie A Montgomery, Jeremy M Simon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2007
Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands
Mark Agulnik, Ezra W E Cohen, Roger B Cohen, et al.
Pigment Cell & Melanoma Research
|
March 18, 2014
Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma
William R Jeck, Joel Parker, Craig C Carson, et al.
Oncogene
|
August 24, 2022
Correction: TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice
Samera H Hamad, Stephanie A Montgomery, Jeremy M Simon, et al.
The Journal of Pathology
|
July 4, 2020
A conditional mouse expressing an activating mutation in NRF2 displays hyperplasia of the upper gastrointestinal tract and decreased white adipose tissue
Brittany M Bowman, Stephanie A Montgomery, Travis P Schrank, et al.
Cancer
|
May 10, 2012
Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN)
K Kian Ang, Amy Chen, Walter J Curran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 6, 2013
Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial
Renato G Martins, Upendra Parvathaneni, Julie E Bauman, et al.
Plos One
|
April 6, 2012
Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma
Chad J Creighton, Anadulce Hernandez-Herrera, Anders Jacobsen, et al.
Page
of 18